Search Results 81-90 of 16861 for Goserelin
Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of this study is to demonstrate the effectiveness of GS-5290, compared to placebo control, in achieving Clinical Response at Week 12. Participation ...
Your doctor will perform a test before you take this medicine. Sevabertinib belongs to the group of medicines called antineoplastics (cancer medicines). It ...
Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.
The purpose of this study is to determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker ...
2025. New genetic biomarker flags aggressive brain tumors Nov. 22, 2025, 03:00 p.m. CDT. 2024. Mayo Clinic names new Department of Neurosurgery chair in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.